Ypsomed
Conrad Cassar is an experienced professional in clinical research and evaluation, currently serving as the Clinical Research and Evaluation Manager at Ypsomed AG since March 2023. Previously, Conrad held the position of Clinical Evaluation Manager and Clinical Evaluation Specialist at Nobel Biocare from May 2018 to the present. Prior experience includes serving as Assistant Biology Divisional Manager at the Malta National Laboratory and working as a Medical Writer at Baxter Healthcare Corporation from 2016 to May 2018. Conrad's educational background includes a Master’s degree in Pharmacy (MPharm) from the University of Malta, where studies were completed from 2001 to 2005.
This person is not in any teams
This person is not in any offices
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.